Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Its subsidiary Wanglaoji Health Company has been recognized as a high-tech enterprise.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that recently, the Office of the National High-Tech Enterprise Certification Management Working Group issued a notice regarding the "Announcement on the Second Supplementary Record of High-Tech Enterprises in Guangdong Province for the 2025 Certification Reporting". The company's subsidiary, Guangzhou Wanglaoji Health Industry Co., Ltd. ("Wanglaoji Health Company"), has been re-certified as a national high-tech enterprise with certificate number GR202544014065, issued on December 19, 2025. This certification of high-tech enterprises for Wanglaoji Health Company is a re-certification conducted after the expiration of the original high-tech enterprise certificate. According to relevant national regulations, Wanglaoji Health Company can enjoy related preferential policies for high-tech enterprises for three consecutive years (2025, 2026, and 2027) after obtaining the high-tech enterprise certification, which includes paying a corporate income tax at a rate of 15%. In 2025, Wanglaoji Health Company has already paid income tax at a rate of 15%. The re-certification as a high-tech enterprise will not have any impact on the financial data of the company for the year 2025.